Wang, Xinshi
He, Ruqian
Zheng, Rongyuan
Ding, Siqi
Wang, Yi
Li, Xueying
Hua, Yingjie
Zeng, Qingyi
Xia, Niange
Zhu, Zhenguo
Kwan, Patrick
Xu, Huiqin http://orcid.org/0000-0002-8856-3048
Funding for this research was provided by:
China Scholarship Council (201808330160)
Zhejiang Medical and Health Science and Technology Project (2019320104)
Article History
First Online: 4 November 2019
Compliance with Ethical Standards
:
: This research was partly supported by the China Scholarship Council (Grant no. 201808330160, to XW) and the Zhejiang Medical and Health Science and Technology Project (grant no. 2019320104, to XW).
: Xinshi Wang has received a grant from the China Scholarship Council (201808330160). Patrick Kwan reports research grants from Biscayne, Eisai, GW Pharmaceuticals, UCB Pharma, LivaNova and Zynerba. He and/or his institution also received speaker’s or consultancy fees from Eisai, LivaNova and UCB Pharma. Huiqin Xu reports speaker’s fees from Novartis and UCB Pharma. Ruqian He, Rongyuan Zheng, Siqi Ding, Yi Wang, Xueying Li, Yingjie Hua, Qingyi Zeng, Niange Xia and Zhenguo Zhu report no disclosures.
: The study was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University.
: The requirement for written informed consent was waived for all of the participants because our study involved no more than minimal risk and involved no procedures for which written consent is normally required outside of the research context.